GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $205,000 | -11.6% | 4,762 | -11.2% | 0.07% | -17.5% |
| Q2 2016 | $232,000 | -3.7% | 5,362 | -9.7% | 0.08% | -7.0% |
| Q1 2016 | $241,000 | +0.4% | 5,938 | 0.0% | 0.09% | +2.4% |
| Q4 2015 | $240,000 | -18.4% | 5,938 | -22.3% | 0.08% | -34.9% |
| Q3 2015 | $294,000 | -13.3% | 7,638 | -6.1% | 0.13% | +26.5% |
| Q2 2015 | $339,000 | -9.8% | 8,138 | 0.0% | 0.10% | -7.3% |
| Q1 2015 | $376,000 | +8.0% | 8,138 | 0.0% | 0.11% | +10.0% |
| Q4 2014 | $348,000 | -7.0% | 8,138 | 0.0% | 0.10% | -6.5% |
| Q3 2014 | $374,000 | -14.0% | 8,138 | 0.0% | 0.11% | -16.4% |
| Q2 2014 | $435,000 | +37.2% | 8,138 | +37.0% | 0.13% | -14.1% |
| Q1 2014 | $317,000 | 0.0% | 5,938 | 0.0% | 0.15% | +4.9% |
| Q4 2013 | $317,000 | -62.9% | 5,938 | -26.4% | 0.14% | +10.1% |
| Q3 2013 | $854,000 | -99.7% | 8,068 | -32.1% | 0.13% | -14.6% |
| Q2 2013 | $296,999,000 | – | 11,876 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |